EDWARDS LIFESCIENCES TO PRESENT AT THE BERNSTEIN 38TH ANNUAL STRATEGIC DECISIONS CONFERENCE
Edwards Lifesciences Corporation (NYSE: EW) announced its participation in the Bernstein 38th Annual Strategic Decisions Conference on June 2, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Edwards Lifesciences Corporation (NYSE: EW) announced its participation in the Bernstein 38th Annual Strategic Decisions Conference on June 2, 2022. CEO Michael A. Mussallem will present at 1:30 p.m. ET. The presentation will be accessible via a live webcast on the company's investor relations website, ir.edwards.com, with an archived version available later the same day. Edwards Lifesciences focuses on patient-centric innovations for structural heart disease and critical care monitoring.
Details
News Market Reaction – EW
The recorded move for EW in the trading session of this news was +1.92%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
IRVINE, Calif., May 23, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced it is scheduled to present at the Bernstein 38th Annual Strategic Decisions Conference on Thursday, June 2, 2022.
Michael A. Mussallem, chairman and chief executive officer, is scheduled to speak to conference attendees at 1:30 p.m. ET. A live webcast of the presentation will be available to all interested parties on the Edwards Lifesciences investor relations website at http://ir.edwards.com/. An archived version of the webcast will be available later that day on the Edwards' investor relations website.
About Edwards Lifesciences
Edwards Lifesciences, is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. We are driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape. For more information, visit Edwards.com and follow us on Facebook, Instagram, LinkedIn, Twitter and YouTube.
Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.
View original content to download multimedia:https://www.prnewswire.com/news-releases/edwards-lifesciences-to-present-at-the-bernstein-38th-annual-strategic-decisions-conference-301552650.html
SOURCE Edwards Lifesciences Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.